3

FORM 3 SUBMISSION

Company: Day One Biopharmaceuticals, Inc.
Filed: May 26, 2021
Period of Report: May 26, 2021
Accession Number: 0001209191-21-036120

View Document ↗ View on SEC.gov ↗